A drug with the SMILES Cc1cc(C)cc(N(CCC(=O)Nc2nnc(C)s2)S(=O)(=O)c2ccc(Cl)cc2)c1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 17.355%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cc(C)cc(N(CCC(=O)Nc2nnc(C)s2)S(=O)(=O)c2ccc(Cl)cc2)c1
Cc1cc(C)cc(N(CCC(=O)Nc2nnc(C)s2)S(=O)(=O)c2ccc(Cl)cc2)c1
3-(N-(4-chlorophenyl)sulfonyl-3,5-dimethylanilino)-N-(5-methyl-1,3,4-thiadiazol-2-yl)propanamide